Stock Events

Stock Events

Avalo Therapeutics (AVTX) Q2 2024 Earnings

13MayConfirmed

Q4 2022

Q2 2023

Q3 2023

Q2 2024

-141

-94.04

-47.07

-0.11

Details

Expected EPS

-1.18

Actual EPS

-141

Surprise EPS

-139.82

Surprise Percent

+11,849.15%

Description

Avalo Therapeutics (AVTX) has reported earnings of -141 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.